L10.5
Drug-induced pemphigus
Clinical Classification Guidelines
Use Additional Code
- code for adverse effect, if applicable, to identify drug (T36-T50 with fifth or sixth character 5)
Medical Intelligence & Overview
Drug-induced pemphigus is a rare autoimmune blistering disorder that occurs as a reaction to certain medications. This condition is characterized by the formation of blistering lesions on the skin and mucous membranes. Although it resembles idiopathic pemphigus, the condition is triggered by specific drugs, and symptoms often resolve after stopping the offending medication. Recognizing this condition is crucial for timely management and preventing unnecessary treatments.
Causes & Symptoms
Clinical Causes: Use of medications such as penicillamine, captopril, and certain antibiotics Long-term treatment with drugs known to induce autoimmune responses Genetic predispositions that may increase susceptibility Exposure to other environmental factors that interact with medications
Key Symptoms: Bullous lesions: fluid-filled blisters on the skin Erosions and ulcers in the mouth and other mucous membranes Skin tenderness and redness around blisters Pain or discomfort associated with oral lesions Possible scaling or crusting of affected areas In severe cases, widespread blistering and skin detachment
Diagnostic & Treatment
Diagnosis Path: Histopathologic examination of skin biopsies showing acantholysis (loss of cell adhesion) in the epidermis Direct immunofluorescence testing revealing deposition of immunoglobulins and complement in the skin Serological tests to detect circulating antibodies against desmogleins, which are typical in pemphigus
Treatment Protocols: Corticosteroids to reduce inflammation and suppress immune activity Immunosuppressive agents, if necessary, to control immune response Supportive care, such as wound dressings and pain management Monitoring for secondary infections due to skin lesions Regular follow-up to assess healing and prevent relapse
Clinical Advice & FAQs
Billing Guidance
Is L10.5 a billable ICD-10 code?
Yes, L10.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report L10.5?
Clinical documentation must specify the nature of Drug-induced pemphigus and any associated comorbidities for accurate reporting.
Cite this Clinical Reference